Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for cancer expressing PDE3A or SLFN12

Compositions and methods for cancer expressing PDE3A or SLFN12

US Patent 11207320 · Granted Dec 28, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Battery cell, battery, and electric apparatus2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseas2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseas2025
4H-pyrrolo[3,2-c]pyridin-4-one derivatives2025
4H-pyrrolo[3,2-c]pyridin-4-one derivatives2025
Anti-TIGIT immunosuppressant and application thereof2025
Identification of PDE3 modulator responsive cancers2025
Identification of PDE3 modulator responsive cancers2025
Dihydrooxadiazinones2025
Dihydrooxadiazinones2025
Dihydrooxadiazinones2025
Dihydrooxadiazinones2025